Clinical Effectiveness and Safety of Erythropoietin‐stimulating Agents for the Treatment of Low‐ and Intermediate‐1−risk Myelodysplastic Syndrome: A Systematic Literature Review

British Journal of Haematology - United Kingdom
doi 10.1111/bjh.15707
Full Text
Abstract

Available in full text

Categories
Hematology
Date
Authors
Publisher

Wiley

Related search

Systematic Literature Review of Treatment Options and Clinical Outcomes for Patients With Higher Risk Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia

Clinical Lymphoma, Myeloma and Leukemia
Cancer ResearchOncologyHematology
2018English

Treatment of Anemia in Low Risk Myelodysplastic Syndromes With Granulocyte–macrophage Colony-Stimulating Factor Plus Recombinant Human Erythropoietin

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
1999English

Systematic Review: Treatment Pattern and Clinical Effectiveness and Safety of Pharmaceutical Therapies for Crohn’s Disease in Europe

Clinical and Experimental Gastroenterology
Gastroenterology
2016English

Clinical Effectiveness and Cost-Effectiveness of Interventions for the Treatment of Anogenital Warts: Systematic Review and Economic Evaluation

Health Technology Assessment
MedicineHealth Policy
2016English

Effectiveness and Safety of Therapeutic Regimens for Elderly Patients With Acute Myeloid Leukemia: A Systematic Literature Review

Clinical Lymphoma, Myeloma and Leukemia
Cancer ResearchOncologyHematology
2018English

A Review of Erythropoietin Abuse: An Analysis of Effectiveness and Safety in Exercise

Journal of Sports Medicine & Doping Studies
2012English

Correction To: The Prognostic Value of Serum Erythropoietin in Patients With Lower-Risk Myelodysplastic Syndromes: A Review of the Literature and Expert Opinion

Annals of Hematology
MedicineHematology
2019English

Clinical Efficacy of Chelation Therapy in Patients With Low-Risk Myelodysplastic Syndrome

Klinicheskaya Onkogematologiya/Clinical Oncohematology
OncologyHematology
2019English

A Systematic Review of the Clinical Effectiveness and Cost-Effectiveness of Pharmalgen® for the Treatment of Bee and Wasp Venom Allergy.

Health Technology Assessment
MedicineHealth Policy
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy